Bright Pharma Caps
Bright Pharma Caps, a leading player in the pharmaceutical industry, is headquartered in the United States and operates across various regions globally. Founded in 2005, the company has established itself as a key provider of high-quality pharmaceutical capsules, catering to both generic and branded markets. Specialising in the development and manufacturing of innovative capsule formulations, Bright Pharma Caps is recognised for its commitment to quality and compliance with stringent industry standards. Their core products include a diverse range of gelatin and vegetarian capsules, which are distinguished by their superior bioavailability and customisation options. With a strong market position, Bright Pharma Caps has achieved notable milestones, including partnerships with major pharmaceutical companies and a reputation for excellence in customer service. The company continues to drive advancements in capsule technology, solidifying its status as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does Bright Pharma Caps's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bright Pharma Caps's score of 3 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bright Pharma Caps's reported carbon emissions
Bright Pharma Caps, headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no documented Scope 1, 2, or 3 emissions to report. Additionally, the company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. In the absence of specific emissions data and reduction initiatives, it is essential to note that many companies in the pharmaceutical sector are increasingly focusing on sustainability and climate action. Bright Pharma Caps may be expected to align with industry standards and practices in the future, potentially adopting strategies to reduce their carbon footprint and enhance their environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bright Pharma Caps is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
